MR
MRNA
Moderna, Inc. Common Stock
$45.72-$2.75 (-5.71%)
Price Chart
Loading chart data...
Key Statistics
Mkt Cap
19.09B
Volume
5.46M
52W High
$59.55
52W Low
$22.28
Open
$47.61
Close
$48.11
Day Range
45.63 - 47.64
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.